Xention Limited
Records under this name other than patents Xention Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,258,138 | Novel Potassium Channel Blockers Formerly held In force · High confidence | In force | High confidence | |
| US 8,372,840 | New Potassium Channel Blockers Formerly held In force · High confidence | In force | High confidence | |
| US 9,073,834 | Potassium Channel Blockers Formerly held In force · High confidence | In force | High confidence | |
| US 9,447,033 | Potassium Channel Blockers Formerly held In force · High confidence | In force | High confidence | |
| US 8,426,442 | Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 8,399,481 | Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 8,673,901 | Novel Potassium Channel Blockers Formerly held Lapsed on the fee record Ended Mar 18, 2026 · High confidence | Lapsed on the fee record | Ended Mar 18, 2026 | High confidence |
| US 7,612,113 | Hydroxy tetrahydro-naphthalenylurea derivatives Formerly held Term ended Term ended Jun 30, 2024 · From the USPTO record | Term ended | Term ended Jun 30, 2024 | From the USPTO record |
| US 8,193,215 | Thieno[2 3-b]pyridines as potassium channel inhibitors Lapsed on the fee record Ended Jun 5, 2020 · From the USPTO record | Lapsed on the fee record | Ended Jun 5, 2020 | From the USPTO record |
| US 10,006,902 | High throughput screen Formerly held Term ended Term ended May 10, 2020 · From the USPTO record | Term ended | Term ended May 10, 2020 | From the USPTO record |